- Home
- Our Team
- Researchers
- Ted Abel, PhD
- Manzar Ashtari, PhD
- Nathan Blum
- Edward Brodkin, MD
- Maja Bucan
- Coralie Chevallier
- Hakon Hakonarson, MD, PhD
- John Herrington, PhD
- Gregor Kohls, PhD
- Susan Levy
- David Mandell, ScD
- Judith Miller
- SARAH PATERSON, PhD
- Jennifer Pinto-Martin, PhD
- Timothy Roberts, PhD
- Anthony Rostain
- ROBERT SCHULTZ, PhD
- Gerard Schellenberg
- Margaret Souders
- Ragini Verma
- Benjamin Yerys
- Clinicians
- Research Post-Doctoral Fellows
- Graduate Students
- Other Staff
- Lawrence Win
- Ming Xie
- Debra Dunn, Esq
- Lorraine Greer
- Katie Lowe
- Preeti Prabhakar
- Gail Stein
- Jessica Beauvais
- Eron Friedlaender, MD
- Leah Gaetz
- Rosa Kim
- Kathy Pinzone, RN, CCRC
- Erica Reisinger
- Tiffany Ryan, MS, MS
- Kathy Gordy
- Ayana King-Pointer
- Katrina Tennant
- Fam Baguio
- Keith Bartley
- Aaron Browne
- Jennifer Bush
- Christine DeLussey
- Maggie Downey
- Julianne Fretz
- Carley Gilman
- Sarah Kauper
- Lori Le
- Megan McCarthy
- Meghan McDermott
- Alana McVey
- Maya Mosner
- Hayley Reed
- Natasha Tonge
- Rukiya Wideman
- Chelsea Zimmerman
- Researchers
- Our Center
- Research
- Trial Interventions
- Autism FAQ
- News
- Events
- Community Initiatives
- What to Expect
- autismMatch
- Art Gallery
- Philadelphia Attractions
- Directions
Stay tuned for details on our 4th annual Huddle Up for Autism, when CAR and the Philadelphia Eagles join together once again to bring families living with autism a day of fun, education, and awareness at Lincoln Financial Field.
Visit CAR's blog, "Driven", for details on last years event.
Trial Interventions
In the 1980s, prevalence rates for autism were estimated at 1 in 1000 children. In 2010, the Centers for Disease Control announced that one in 110 children is diagnosed with an autism spectrum disorder. With the rise in prevalence has come a rise in the number of new treatments. However, there is not enough research into the effectiveness of these treatments and even less research about which treatments work best for which kids. Yet schools are federally mandated to use "evidence-based" treatments and insurance companies often won't pay for treatments without scientific evidence of benefit.
CAR is dedicated both to testing existing treatments and developing new ones that may help individuals living with autism. By studying not only whether a treatment works, but for whom it works and under what circumstances, we hope to minimize the time families spend searching for the elusive program that will help.